These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25995466)

  • 1. Blocking stroke-induced immunodeficiency increases CNS antigen-specific autoreactivity but does not worsen functional outcome after experimental stroke.
    Römer C; Engel O; Winek K; Hochmeister S; Zhang T; Royl G; Klehmet J; Dirnagl U; Meisel C; Meisel A
    J Neurosci; 2015 May; 35(20):7777-94. PubMed ID: 25995466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Ischemia Induces Diversified Neuroantigen-Specific T-Cell Responses That Exacerbate Brain Injury.
    Jin WN; Gonzales R; Feng Y; Wood K; Chai Z; Dong JF; La Cava A; Shi FD; Liu Q
    Stroke; 2018 Jun; 49(6):1471-1478. PubMed ID: 29695462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.
    Chyuan IT; Tsai HF; Wu CS; Sung CC; Hsu PN
    Front Immunol; 2018; 9():15. PubMed ID: 29403497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelin specific cells infiltrate MCAO lesions and exacerbate stroke severity.
    Ren X; Akiyoshi K; Grafe MR; Vandenbark AA; Hurn PD; Herson PS; Offner H
    Metab Brain Dis; 2012 Mar; 27(1):7-15. PubMed ID: 21989743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells.
    Frenkel D; Huang Z; Maron R; Koldzic DN; Hancock WW; Moskowitz MA; Weiner HL
    J Immunol; 2003 Dec; 171(12):6549-55. PubMed ID: 14662856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of anergy by antibody blockade of TCR in myelin oligodendrocyte glycoprotein-specific cells.
    Wasserman HA; Evavold BD
    J Immunol; 2008 Jun; 180(11):7259-64. PubMed ID: 18490725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis.
    Kohm AP; Carpentier PA; Anger HA; Miller SD
    J Immunol; 2002 Nov; 169(9):4712-6. PubMed ID: 12391178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
    Mony JT; Khorooshi R; Owens T
    Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
    Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
    J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
    Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
    Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis.
    Sun Y; Lin X; Chen HM; Wu Q; Subudhi SK; Chen L; Fu YX
    J Immunol; 2002 Feb; 168(3):1457-65. PubMed ID: 11801689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of sympathetic nervous system and hypothalamic-pituitary-adrenal axis on systemic immune cells after severe experimental stroke.
    Mracsko E; Liesz A; Karcher S; Zorn M; Bari F; Veltkamp R
    Brain Behav Immun; 2014 Oct; 41():200-9. PubMed ID: 24886966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen.
    Kinzel S; Lehmann-Horn K; Torke S; Häusler D; Winkler A; Stadelmann C; Payne N; Feldmann L; Saiz A; Reindl M; Lalive PH; Bernard CC; Brück W; Weber MS
    Acta Neuropathol; 2016 Jul; 132(1):43-58. PubMed ID: 27022743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis.
    Sewell DL; Reinke EK; Co DO; Hogan LH; Fritz RB; Sandor M; Fabry Z
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):564-72. PubMed ID: 12853387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines.
    Lees JR; Iwakura Y; Russell JH
    J Immunol; 2008 Jun; 180(12):8066-72. PubMed ID: 18523270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-oriented T cell migration contributes to myelin peptide induced-EAE and immune tolerance.
    Zheng P; Fu H; Wei G; Wei Z; Zhang J; Ma X; Rui D; Meng X; Ming L
    Clin Immunol; 2016 Aug; 169():36-46. PubMed ID: 27327113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice.
    Sun D; Whitaker JN; Huang Z; Liu D; Coleclough C; Wekerle H; Raine CS
    J Immunol; 2001 Jun; 166(12):7579-87. PubMed ID: 11390514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scavenger Receptor A Mediates the Clearance and Immunological Screening of MDA-Modified Antigen by M2-Type Macrophages.
    Warnecke A; Abele S; Musunuri S; Bergquist J; Harris RA
    Neuromolecular Med; 2017 Dec; 19(4):463-479. PubMed ID: 28828577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR7 on CD4
    Belikan P; Bühler U; Wolf C; Pramanik GK; Gollan R; Zipp F; Siffrin V
    J Immunol; 2018 Apr; 200(8):2554-2562. PubMed ID: 29549177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.